Company Profile
Esperion Therapeutics Stock Price, News & Analysis
- Ticker:
- ESPR
- Exchange:
- NASDAQ
- Sector:
- Biotechnology
- Location:
- Headquartered in the United States and listed on NASDAQ, Esperion Therapeutics is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts.
Stock performance
3.16 USD (0.00%)
Close
Last updated: June 23, 2026 at 00:00
814.31M USD
Market cap
Why the stock is moving
ESPR is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
Esperion Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Esperion Therapeutics is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts.
Business Model Characteristics
Esperion Therapeutics follows a pipeline-led model where clinical readouts, filing updates, and program expansion determine how the market underwrites the story.
Position Within the Biotechnology Landscape
Compared with more mature healthcare names, Esperion Therapeutics sits on the development side of the biotech landscape, where catalyst timing can reprice the stock quickly.
Future catalysts
Recent news
The five most recent feed items are shown below in reverse chronological order.
- 01
- 02
Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Source: Esperion Therapeutics
- 03
- 04
Esperion to Report Fourth Quarter and Full Year 2025 Financial Results on March 10
Source: Esperion Therapeutics
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Esperion Therapeutics (ESPR)?
Esperion Therapeutics (ESPR) most recently closed at 3.16 USD, a 0.00% move versus the previous session.
What is the market cap of Esperion Therapeutics (ESPR)?
Esperion Therapeutics currently has a market capitalization of 814.31M USD on BioPharmSignal.
What does Esperion Therapeutics do?
Esperion Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
On which exchange is ESPR stock listed?
Esperion Therapeutics (ESPR) is associated with NASDAQ, Headquartered in the United States and listed on NASDAQ, Esperion Therapeutics is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts., Biotechnology.
What is Esperion?
Esperion Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
Which conditions is Esperion Therapeutics targeting with Esperion?
Esperion Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
What is Therapeutics?
Esperion Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.